Search All Applications in Cannabis: Compositions
Application US20200061023
Published 2020-02-27
Compositions And Methods For Delivering Tetrahydrocannabinol And Ketone Bodies
Disclosed herein are “ketannabis” (or “ketonnabis”) compositions including a combination of: (1) tetrahydrocannabinol (THC); (2) a ketone body component such as beta-hydroxybutyrate (BHB) and/or acetoacetate; and (3) a dietetically or pharmaceutically acceptable carrier. Also disclosed herein are methods of using such ketannabis compositions for producing desired physiological effects. The ketannabis compositions beneficially enhance the euphoric effects of THC without aggravating common side effects or even acting to reduce common side effects such as anxiety, disruption of short-term memory, appetite increases, heart rate increases, and blood pressure changes.
Much More than Average Length Specification
View the Patent Matrix® Diagram to Explore the Claim Relationships
USPTO Full Text Publication >
- 1-16. (canceled)
- 17. A method for administering ketone bodies and tetrahydrocannabinol (THC) to a mammal, comprising:
administering a ketone body component selected from beta-hydroxybutyrate (BHB) salts, BHB esters, BHB acid, acetoacetate salts, acetoacetate esters, acetoacetic acid, and combinations thereof; administering a THC component and the ketone body component raising blood ketone level in the mammal.
- 19. (canceled)
- 22. (canceled)
- 23. (canceled)
- 25. (canceled)
- 46. A method for promoting euphoric effects in a mammal, the method comprising:
administering a ketone body component selected from beta-hydroxybutyrate (BHB) salts, BHB esters, BHB acid, acetoacetate salts, acetoacetate esters, acetoacetic acid, and combinations thereof; administering a THC component; and the administering of the ketone body component and the THC component provides one or both of
promoting euphoric effects in the mammal to a greater degree than a composition containing the same amount of THC but without a ketone body component, or
promoting euphoric effects in the mammal while maintaining or reducing negative side effects as compared to a composition containing the same amount of THC but without a ketone body component.
- 49. A method for promoting ketosis in a mammal, the method comprising:
administering a ketone body component selected from beta-hydroxybutyrate (BHB) salts, BHB esters, BHB acid, acetoacetate salts, acetoacetate esters, acetoacetic acid, and combinations thereof; administering a THC component; and the administering of the ketone body component and the THC component induces sustained ketosis in the mammal with reduced symptoms of at least one of hypoglycemia, keto flu, or depression relative to a ketone body composition omitting THC.
